The basal levels of active and inactive plasma renin concentration in infancy and childhood

Insights

Plasma renin activity and concentration decrease with age in children. Active renin correlates with activity, while inactive renin does not, with inactive renin comprising 79% of the total.

Area of Science:

  • Pediatric Endocrinology
  • Renal Physiology
  • Biochemistry

Background:

  • The renin-angiotensin-aldosterone system (RAAS) plays a crucial role in blood pressure regulation.
  • Understanding developmental changes in the RAAS components, like renin, is vital in pediatric health.
  • Plasma renin exists in active and inactive forms, with implications for RAAS regulation.

Purpose of the Study:

  • To investigate age-related changes in basal plasma renin activity, active renin concentration, and inactive renin concentration in healthy children.
  • To determine the relationship between active and inactive renin concentrations and plasma renin activity.
  • To assess the proportion of inactive renin in children and its relation to age.

Main Methods:

  • Measurement of basal plasma renin activity (PRA), active plasma renin concentration (PRC), and inactive PRC in 89 healthy children.
  • Participants ranged in age from 1 week to 16 years and were in a recumbent position.
  • Statistical analysis included correlation coefficients to assess relationships between variables and age.

Main Results:

  • A significant age-related decrease was observed for active PRC (r = -0.60), inactive PRC (r = -0.59), and total PRC (r = -0.66) (P < 0.001).
  • After adjusting for age, active PRC strongly correlated with PRA (r = 0.81) but showed no significant correlation with inactive PRC (r = 0.18).
  • The proportion of inactive renin was not age-dependent, with an overall average of 79% inactive renin.

Conclusions:

  • Plasma renin activity and concentration significantly decline with age throughout childhood.
  • Active renin concentration is a reliable indicator of plasma renin activity in children, independent of inactive renin levels.
  • A substantial proportion of circulating renin in children exists in an inactive form, a characteristic that remains consistent across different ages.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...